Dietary Supplement
Apigenin
Apigenin is a dietary supplement with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_1
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (33.3%)
N/A2 (66.7%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Cryopreservation Medium With Apigenin on Post-thaw Human Sperm
NCT06560216
completedphase_1
Improvement of Organ Function by Apigenin in Elderly Patients With Sepsis
NCT05999682
completednot_applicable
Absorption, Metabolism and Excretion of Apigenin and Apigenin Glycosides
NCT03526081
Clinical Trials (3)
Showing 3 of 3 trials
NCT06560216Not Applicable
Cryopreservation Medium With Apigenin on Post-thaw Human Sperm
NCT05999682Phase 1
Improvement of Organ Function by Apigenin in Elderly Patients With Sepsis
NCT03526081Not Applicable
Absorption, Metabolism and Excretion of Apigenin and Apigenin Glycosides
All 3 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 3